Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Title
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
Authors
Keywords
ATP-binding site, Catalytic spine, K/E/D/D, Regulatory spine, Ruxolitinib, Tofacitinib
Journal
PHARMACOLOGICAL RESEARCH
Volume 111, Issue -, Pages 784-803
Publisher
Elsevier BV
Online
2016-07-28
DOI
10.1016/j.phrs.2016.07.038

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now